Synthesis and Biocompatibility of Carboplatin-Loaded PEG-PLGA Nanoparticles for Mesenchymal Stem Cell-Mediated Cancer Therapy
Authors:
Open Access
- 10 April 2026
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (4) , 411
Abstract
Purpose: Biocompatibility is a critical requirement for nanoparticle-loaded mesenchymal stem cells (MSCs) used in targeted cancer therapy. This study aimed to evaluate the compatibility of carboplatin-loaded PEG–PLGA nanoparticles (CRB@PEG–PLGA) with adipose tissue-derived mesenchymal stem cells (ADSCs). Methods: CRB@PEG–PLGA nanoparticles were synthesized using a double emulsion solvent evaporation method and characterized by dynamic light scattering (DLS), Fourier-transform infrared spectroscopy (FT-IR), and scanning electron microscopy (SEM). Isolated ADSCs were validated by surface marker expression and differentiation assays. Nanoparticle size, zeta potential, encapsulation efficiency (EE), and drug loading capacity (LC) were determined. Biocompatibility was assessed using a 24-hour MTT assay at increasing concentrations up to 7000 ng/mL. Results: The nanoparticles exhibited a mean hydrodynamic diameter of 181.3 ± 9.07 nm, a zeta potential of − 14.1 ± 0.71 mV, an encapsulation efficiency of 66.4 ± 3.6%, and a drug loading capacity of 16.5 ± 5.8%. In vitro cytotoxicity analysis demonstrated that ADSCs treated with CRB@PEG–PLGA maintained approximately 64.86% viability at the highest tested concentration, showing significantly improved biocompatibility compared to free carboplatin. Drug-free PEG–PLGA nanoparticles exhibited minimal cytotoxicity. Conclusion: CRB@PEG–PLGA nanoparticles demonstrate favorable physicochemical properties and acceptable biocompatibility with ADSCs, supporting their potential application as a carrier platform in MSC-based targeted cancer therapy.Keywords
Funding Information
- Ege University
This publication has 64 references indexed in Scilit:
- Design and optimization of a novel herbosomal-loaded PEG–poloxamer topical formulation for the treatment of cold injuries: a quality-by-design approachDrug Delivery and Translational Research, 2022
- Tuning the Size of Poly(lactic‐co‐glycolic Acid) (PLGA) Nanoparticles Fabricated by NanoprecipitationBiotechnology Journal, 2017
- Effect of Cisplatin on Ultrastructure and Viability of Adipose-Derived Mesenchymal Stem CellsBioNanoScience, 2016
- Stem Cell Membrane‐Coated Nanogels for Highly Efficient In Vivo Tumor Targeted Drug DeliverySmall, 2016
- PEGylation as a strategy for improving nanoparticle-based drug and gene deliveryAdvanced Drug Delivery Reviews, 2016
- Human adipose tissue derived mesenchymal stem cells are resistant to several chemotherapeutic agentsCytotechnology, 2011
- PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effectAdvanced Drug Delivery Reviews, 2011
- Adsorption of the PtII Anticancer Drug Carboplatin by Mesoporous SilicaChemistry & Biodiversity, 2009
- In vitro effect of carboplatin, cytarabine, paclitaxel, vincristine, and low‐power laser irradiation on murine mesenchymal stem cellsLasers in Surgery and Medicine, 2009
- A simple equation for description of solute release II. Fickian and anomalous release from swellable devicesJournal of Controlled Release, 1987